Global Aminoglycosides Market Research Report 2024
Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial therapeutic agents that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside (sugar); the term can also refer more generally to any organic molecule that contains aminosugar substructures. Aminoglycoside antibiotics display bactericidal activity against Gram-negative aerobes and some anaerobic bacilli where resistance has not yet arisen but generally not against Gram-positive and anaerobic Gram-negative bacteria.
According to Mr Accuracy reports’s new survey, global Aminoglycosides market is projected to reach US$ 1183.4 million in 2034, increasing from US$ 1050.2 million in 2024, with the CAGR of 1.7% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aminoglycosides market research.
Asia Pacific accounted for the largest share of revenue in 2014 that is due to higher incidence rate of multi-drug resistant tuberculosis that needs second line drugs for treatment is attributive towards a larger considerably larger share of kanamycin and capreomycin in the Asia Pacific region along with the significant availability of other aminoglycosides as well.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aminoglycosides market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Kremoint Pharma Pvt.
Vega Pharma
Jiangxi Bolai Pharmacy,
Xian Wison Biological Technology,
Hangzhou Uniwise International,
HuvePharma
Yi Chang Veterinary Medicine Factory
Medson Pharmaceuticals
Medico Remedies
Segment by Type
Neomycin
Tobramycin
Gentamicin
Amikacin
Paromomycin
Streptomycin
Kanamycin
Others
Segment by Application
Skin Infection
Respiratory Diseases
UTI & Pelvic Diseases
Other Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Aminoglycosides report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Table of Content
1 Aminoglycosides Market Overview
1.1 Product Overview and Scope of Aminoglycosides
1.2 Aminoglycosides Segment by Type
1.2.1 Global Aminoglycosides Market Value Comparison by Type (2024-2034)
1.2.2 Neomycin
1.2.3 Tobramycin
1.2.4 Gentamicin
1.2.5 Amikacin
1.2.6 Paromomycin
1.2.7 Streptomycin
1.2.8 Kanamycin
1.2.9 Others
1.3 Aminoglycosides Segment by Application
1.3.1 Global Aminoglycosides Market Value by Application: (2024-2034)
1.3.2 Skin Infection
1.3.3 Respiratory Diseases
1.3.4 UTI & Pelvic Diseases
1.3.5 Other Diseases
1.4 Global Aminoglycosides Market Size Estimates and Forecasts
1.4.1 Global Aminoglycosides Revenue 2018-2034
1.4.2 Global Aminoglycosides Sales 2018-2034
1.4.3 Global Aminoglycosides Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Aminoglycosides Market Competition by Manufacturers
2.1 Global Aminoglycosides Sales Market Share by Manufacturers (2018-2023)
2.2 Global Aminoglycosides Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Aminoglycosides Average Price by Manufacturers (2018-2023)
2.4 Global Aminoglycosides Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Aminoglycosides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aminoglycosides, Product Type & Application
2.7 Aminoglycosides Market Competitive Situation and Trends
2.7.1 Aminoglycosides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Aminoglycosides Players Market Share by Revenue
2.7.3 Global Aminoglycosides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Aminoglycosides Retrospective Market Scenario by Region
3.1 Global Aminoglycosides Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Aminoglycosides Global Aminoglycosides Sales by Region: 2018-2034
3.2.1 Global Aminoglycosides Sales by Region: 2018-2023
3.2.2 Global Aminoglycosides Sales by Region: 2024-2034
3.3 Global Aminoglycosides Global Aminoglycosides Revenue by Region: 2018-2034
3.3.1 Global Aminoglycosides Revenue by Region: 2018-2023
3.3.2 Global Aminoglycosides Revenue by Region: 2024-2034
3.4 North America Aminoglycosides Market Facts & Figures by Country
3.4.1 North America Aminoglycosides Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Aminoglycosides Sales by Country (2018-2034)
3.4.3 North America Aminoglycosides Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aminoglycosides Market Facts & Figures by Country
3.5.1 Europe Aminoglycosides Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Aminoglycosides Sales by Country (2018-2034)
3.5.3 Europe Aminoglycosides Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aminoglycosides Market Facts & Figures by Country
3.6.1 Asia Pacific Aminoglycosides Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Aminoglycosides Sales by Country (2018-2034)
3.6.3 Asia Pacific Aminoglycosides Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aminoglycosides Market Facts & Figures by Country
3.7.1 Latin America Aminoglycosides Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Aminoglycosides Sales by Country (2018-2034)
3.7.3 Latin America Aminoglycosides Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aminoglycosides Market Facts & Figures by Country
3.8.1 Middle East and Africa Aminoglycosides Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Aminoglycosides Sales by Country (2018-2034)
3.8.3 Middle East and Africa Aminoglycosides Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Aminoglycosides Sales by Type (2018-2034)
4.1.1 Global Aminoglycosides Sales by Type (2018-2023)
4.1.2 Global Aminoglycosides Sales by Type (2024-2034)
4.1.3 Global Aminoglycosides Sales Market Share by Type (2018-2034)
4.2 Global Aminoglycosides Revenue by Type (2018-2034)
4.2.1 Global Aminoglycosides Revenue by Type (2018-2023)
4.2.2 Global Aminoglycosides Revenue by Type (2024-2034)
4.2.3 Global Aminoglycosides Revenue Market Share by Type (2018-2034)
4.3 Global Aminoglycosides Price by Type (2018-2034)
5 Segment by Application
5.1 Global Aminoglycosides Sales by Application (2018-2034)
5.1.1 Global Aminoglycosides Sales by Application (2018-2023)
5.1.2 Global Aminoglycosides Sales by Application (2024-2034)
5.1.3 Global Aminoglycosides Sales Market Share by Application (2018-2034)
5.2 Global Aminoglycosides Revenue by Application (2018-2034)
5.2.1 Global Aminoglycosides Revenue by Application (2018-2023)
5.2.2 Global Aminoglycosides Revenue by Application (2024-2034)
5.2.3 Global Aminoglycosides Revenue Market Share by Application (2018-2034)
5.3 Global Aminoglycosides Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Kremoint Pharma Pvt.
6.1.1 Kremoint Pharma Pvt. Corporation Information
6.1.2 Kremoint Pharma Pvt. Description and Business Overview
6.1.3 Kremoint Pharma Pvt. Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Kremoint Pharma Pvt. Aminoglycosides Product Portfolio
6.1.5 Kremoint Pharma Pvt. Recent Developments/Updates
6.2 Vega Pharma
6.2.1 Vega Pharma Corporation Information
6.2.2 Vega Pharma Description and Business Overview
6.2.3 Vega Pharma Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Vega Pharma Aminoglycosides Product Portfolio
6.2.5 Vega Pharma Recent Developments/Updates
6.3 Jiangxi Bolai Pharmacy,
6.3.1 Jiangxi Bolai Pharmacy, Corporation Information
6.3.2 Jiangxi Bolai Pharmacy, Description and Business Overview
6.3.3 Jiangxi Bolai Pharmacy, Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Jiangxi Bolai Pharmacy, Aminoglycosides Product Portfolio
6.3.5 Jiangxi Bolai Pharmacy, Recent Developments/Updates
6.4 Xian Wison Biological Technology,
6.4.1 Xian Wison Biological Technology, Corporation Information
6.4.2 Xian Wison Biological Technology, Description and Business Overview
6.4.3 Xian Wison Biological Technology, Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Xian Wison Biological Technology, Aminoglycosides Product Portfolio
6.4.5 Xian Wison Biological Technology, Recent Developments/Updates
6.5 Hangzhou Uniwise International,
6.5.1 Hangzhou Uniwise International, Corporation Information
6.5.2 Hangzhou Uniwise International, Description and Business Overview
6.5.3 Hangzhou Uniwise International, Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Hangzhou Uniwise International, Aminoglycosides Product Portfolio
6.5.5 Hangzhou Uniwise International, Recent Developments/Updates
6.6 HuvePharma
6.6.1 HuvePharma Corporation Information
6.6.2 HuvePharma Description and Business Overview
6.6.3 HuvePharma Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.6.4 HuvePharma Aminoglycosides Product Portfolio
6.6.5 HuvePharma Recent Developments/Updates
6.7 Yi Chang Veterinary Medicine Factory
6.6.1 Yi Chang Veterinary Medicine Factory Corporation Information
6.6.2 Yi Chang Veterinary Medicine Factory Description and Business Overview
6.6.3 Yi Chang Veterinary Medicine Factory Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Yi Chang Veterinary Medicine Factory Aminoglycosides Product Portfolio
6.7.5 Yi Chang Veterinary Medicine Factory Recent Developments/Updates
6.8 Medson Pharmaceuticals
6.8.1 Medson Pharmaceuticals Corporation Information
6.8.2 Medson Pharmaceuticals Description and Business Overview
6.8.3 Medson Pharmaceuticals Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medson Pharmaceuticals Aminoglycosides Product Portfolio
6.8.5 Medson Pharmaceuticals Recent Developments/Updates
6.9 Medico Remedies
6.9.1 Medico Remedies Corporation Information
6.9.2 Medico Remedies Description and Business Overview
6.9.3 Medico Remedies Aminoglycosides Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Medico Remedies Aminoglycosides Product Portfolio
6.9.5 Medico Remedies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aminoglycosides Industry Chain Analysis
7.2 Aminoglycosides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aminoglycosides Production Mode & Process
7.4 Aminoglycosides Sales and Marketing
7.4.1 Aminoglycosides Sales Channels
7.4.2 Aminoglycosides Distributors
7.5 Aminoglycosides Customers
8 Aminoglycosides Market Dynamics
8.1 Aminoglycosides Industry Trends
8.2 Aminoglycosides Market Drivers
8.3 Aminoglycosides Market Challenges
8.4 Aminoglycosides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Figure
List of Tables
Table 1. Global Aminoglycosides Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Aminoglycosides Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Aminoglycosides Market Competitive Situation by Manufacturers in 2024
Table 4. Global Aminoglycosides Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Aminoglycosides Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Aminoglycosides Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Aminoglycosides Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Aminoglycosides Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Aminoglycosides, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Aminoglycosides, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Aminoglycosides, Product Type & Application
Table 12. Global Key Manufacturers of Aminoglycosides, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Aminoglycosides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycosides as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Aminoglycosides Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Aminoglycosides Sales by Region (2018-2023) & (K Units)
Table 18. Global Aminoglycosides Sales Market Share by Region (2018-2023)
Table 19. Global Aminoglycosides Sales by Region (2024-2034) & (K Units)
Table 20. Global Aminoglycosides Sales Market Share by Region (2024-2034)
Table 21. Global Aminoglycosides Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Aminoglycosides Revenue Market Share by Region (2018-2023)
Table 23. Global Aminoglycosides Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Aminoglycosides Revenue Market Share by Region (2024-2034)
Table 25. North America Aminoglycosides Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Aminoglycosides Sales by Country (2018-2023) & (K Units)
Table 27. North America Aminoglycosides Sales by Country (2024-2034) & (K Units)
Table 28. North America Aminoglycosides Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Aminoglycosides Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Aminoglycosides Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Aminoglycosides Sales by Country (2018-2023) & (K Units)
Table 32. Europe Aminoglycosides Sales by Country (2024-2034) & (K Units)
Table 33. Europe Aminoglycosides Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Aminoglycosides Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Aminoglycosides Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Aminoglycosides Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Aminoglycosides Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Aminoglycosides Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Aminoglycosides Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Aminoglycosides Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Aminoglycosides Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Aminoglycosides Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Aminoglycosides Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Aminoglycosides Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Aminoglycosides Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Aminoglycosides Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Aminoglycosides Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Aminoglycosides Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Aminoglycosides Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Aminoglycosides Sales (K Units) by Type (2018-2023)
Table 51. Global Aminoglycosides Sales (K Units) by Type (2024-2034)
Table 52. Global Aminoglycosides Sales Market Share by Type (2018-2023)
Table 53. Global Aminoglycosides Sales Market Share by Type (2024-2034)
Table 54. Global Aminoglycosides Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Aminoglycosides Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Aminoglycosides Revenue Market Share by Type (2018-2023)
Table 57. Global Aminoglycosides Revenue Market Share by Type (2024-2034)
Table 58. Global Aminoglycosides Price (USD/Unit) by Type (2018-2023)
Table 59. Global Aminoglycosides Price (USD/Unit) by Type (2024-2034)
Table 60. Global Aminoglycosides Sales (K Units) by Application (2018-2023)
Table 61. Global Aminoglycosides Sales (K Units) by Application (2024-2034)
Table 62. Global Aminoglycosides Sales Market Share by Application (2018-2023)
Table 63. Global Aminoglycosides Sales Market Share by Application (2024-2034)
Table 64. Global Aminoglycosides Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Aminoglycosides Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Aminoglycosides Revenue Market Share by Application (2018-2023)
Table 67. Global Aminoglycosides Revenue Market Share by Application (2024-2034)
Table 68. Global Aminoglycosides Price (USD/Unit) by Application (2018-2023)
Table 69. Global Aminoglycosides Price (USD/Unit) by Application (2024-2034)
Table 70. Kremoint Pharma Pvt. Corporation Information
Table 71. Kremoint Pharma Pvt. Description and Business Overview
Table 72. Kremoint Pharma Pvt. Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Kremoint Pharma Pvt. Aminoglycosides Product
Table 74. Kremoint Pharma Pvt. Recent Developments/Updates
Table 75. Vega Pharma Corporation Information
Table 76. Vega Pharma Description and Business Overview
Table 77. Vega Pharma Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Vega Pharma Aminoglycosides Product
Table 79. Vega Pharma Recent Developments/Updates
Table 80. Jiangxi Bolai Pharmacy, Corporation Information
Table 81. Jiangxi Bolai Pharmacy, Description and Business Overview
Table 82. Jiangxi Bolai Pharmacy, Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Jiangxi Bolai Pharmacy, Aminoglycosides Product
Table 84. Jiangxi Bolai Pharmacy, Recent Developments/Updates
Table 85. Xian Wison Biological Technology, Corporation Information
Table 86. Xian Wison Biological Technology, Description and Business Overview
Table 87. Xian Wison Biological Technology, Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Xian Wison Biological Technology, Aminoglycosides Product
Table 89. Xian Wison Biological Technology, Recent Developments/Updates
Table 90. Hangzhou Uniwise International, Corporation Information
Table 91. Hangzhou Uniwise International, Description and Business Overview
Table 92. Hangzhou Uniwise International, Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Hangzhou Uniwise International, Aminoglycosides Product
Table 94. Hangzhou Uniwise International, Recent Developments/Updates
Table 95. HuvePharma Corporation Information
Table 96. HuvePharma Description and Business Overview
Table 97. HuvePharma Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. HuvePharma Aminoglycosides Product
Table 99. HuvePharma Recent Developments/Updates
Table 100. Yi Chang Veterinary Medicine Factory Corporation Information
Table 101. Yi Chang Veterinary Medicine Factory Description and Business Overview
Table 102. Yi Chang Veterinary Medicine Factory Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Yi Chang Veterinary Medicine Factory Aminoglycosides Product
Table 104. Yi Chang Veterinary Medicine Factory Recent Developments/Updates
Table 105. Medson Pharmaceuticals Corporation Information
Table 106. Medson Pharmaceuticals Description and Business Overview
Table 107. Medson Pharmaceuticals Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Medson Pharmaceuticals Aminoglycosides Product
Table 109. Medson Pharmaceuticals Recent Developments/Updates
Table 110. Medico Remedies Corporation Information
Table 111. Medico Remedies Description and Business Overview
Table 112. Medico Remedies Aminoglycosides Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Medico Remedies Aminoglycosides Product
Table 114. Medico Remedies Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Aminoglycosides Distributors List
Table 118. Aminoglycosides Customers List
Table 119. Aminoglycosides Market Trends
Table 120. Aminoglycosides Market Drivers
Table 121. Aminoglycosides Market Challenges
Table 122. Aminoglycosides Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Aminoglycosides
Figure 2. Global Aminoglycosides Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Aminoglycosides Market Share by Type in 2024 & 2034
Figure 4. Neomycin Product Picture
Figure 5. Tobramycin Product Picture
Figure 6. Gentamicin Product Picture
Figure 7. Amikacin Product Picture
Figure 8. Paromomycin Product Picture
Figure 9. Streptomycin Product Picture
Figure 10. Kanamycin Product Picture
Figure 11. Others Product Picture
Figure 12. Global Aminoglycosides Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 13. Global Aminoglycosides Market Share by Application in 2024 & 2034
Figure 14. Skin Infection
Figure 15. Respiratory Diseases
Figure 16. UTI & Pelvic Diseases
Figure 17. Other Diseases
Figure 18. Global Aminoglycosides Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global Aminoglycosides Market Size (2018-2034) & (US$ Million)
Figure 20. Global Aminoglycosides Sales (2018-2034) & (K Units)
Figure 21. Global Aminoglycosides Average Price (USD/Unit) & (2018-2034)
Figure 22. Aminoglycosides Report Years Considered
Figure 23. Aminoglycosides Sales Share by Manufacturers in 2024
Figure 24. Global Aminoglycosides Revenue Share by Manufacturers in 2024
Figure 25. The Global 5 and 10 Largest Aminoglycosides Players: Market Share by Revenue in 2024
Figure 26. Aminoglycosides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 27. Global Aminoglycosides Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 28. North America Aminoglycosides Sales Market Share by Country (2018-2034)
Figure 29. North America Aminoglycosides Revenue Market Share by Country (2018-2034)
Figure 30. U.S. Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Canada Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Europe Aminoglycosides Sales Market Share by Country (2018-2034)
Figure 33. Europe Aminoglycosides Revenue Market Share by Country (2018-2034)
Figure 34. Germany Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. France Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. U.K. Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Italy Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Russia Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Asia Pacific Aminoglycosides Sales Market Share by Region (2018-2034)
Figure 40. Asia Pacific Aminoglycosides Revenue Market Share by Region (2018-2034)
Figure 41. China Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Japan Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. South Korea Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. India Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Australia Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Taiwan Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Indonesia Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Thailand Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Malaysia Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Philippines Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Latin America Aminoglycosides Sales Market Share by Country (2018-2034)
Figure 52. Latin America Aminoglycosides Revenue Market Share by Country (2018-2034)
Figure 53. Mexico Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Brazil Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Argentina Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Middle East & Africa Aminoglycosides Sales Market Share by Country (2018-2034)
Figure 57. Middle East & Africa Aminoglycosides Revenue Market Share by Country (2018-2034)
Figure 58. Turkey Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 59. Saudi Arabia Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 60. U.A.E Aminoglycosides Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 61. Global Sales Market Share of Aminoglycosides by Type (2018-2034)
Figure 62. Global Revenue Market Share of Aminoglycosides by Type (2018-2034)
Figure 63. Global Aminoglycosides Price (USD/Unit) by Type (2018-2034)
Figure 64. Global Sales Market Share of Aminoglycosides by Application (2018-2034)
Figure 65. Global Revenue Market Share of Aminoglycosides by Application (2018-2034)
Figure 66. Global Aminoglycosides Price (USD/Unit) by Application (2018-2034)
Figure 67. Aminoglycosides Value Chain
Figure 68. Aminoglycosides Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed